Home » abbvie

You Searched For "AbbVie"

AbbVie said that after 14 weeks of treatment, 69 percent of patients receiving a 30 milligram dose of the drug and 65 percent of patients receiving a 15 mg dose reported improvements in physical function. (Photo: Pixabay)

AbbVie rheumatoid arthritis drug succeeds in late stage trial

The U.S. drugmaker hopes the drug, upadacitinib, can help replace lost revenue from its top-selling RA treatment Humira.

24 Oct 2018 11:15 AM IST

AbbVie Inc would acquire Botox-maker Allergan Plc in a cash-and-stock deal for about USD 63 billion.

AbbVie to buy Botox-maker Allergan in USD 63 billion deal

Allergan shareholders will receive 0.8660 AbbVie shares and USD 120.30 in cash for each share held.

25 Jun 2019 4:43 PM IST